Uxin Limited Sponsored ADR UXIN
1.31
0.01
0.77%
as of 25 Sep
- Market cap
- $272.1M
- P/E
- 0.0×
Follow UXIN
Insider Buys
alert about insiders buying in the last 12 month
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| P/E ratio | 0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
| P/S ratio | 1.24 | 1.52 | 2.08 | 2.59 | |
| P/FCF ratio | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/Operating CF | (9.43) | (9.77) | (33.97) | (34.23) | |
| P/B ratio | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price to Tangible BV | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Sales | 1.60 | 1.96 | 2.58 | 3.25 | |
| EV/EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Operating CF | (5.27) | (5.43) | (4.03) | (4.09) | |
| EV/FCF | (4.96) | (5.11) | (3.86) | (3.92) | |
| Quick Ratio | 0.10 | 0.11 | 0.12 | 0.13 | |
| Current Ratio | 0.79 | 0.76 | 0.72 | 0.69 | |
| Net Debt/EBITDA | (20.66) | (22.79) | (34.90) | (31.19) | |
| Debt/Assets | 63.88% | 61.54% | 59.98% | 69.19% | |
| Debt/Equity | (4.47) | (6.45) | (6.58) | (4.96) | |
| Asset Turnover | 1.84 | 1.50 | 1.25 | 2.02 | |
| Operating CF/Net income | 0.00 | 5.46 | 0.00 | 2.11 | |
| Capex/Depreciation | — | (0.34) | — | (0.27) | |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | |
| Research and Development Expense of Revenue | 0.27% | 0.29% | 0.35% | 0.47% | |
| Selling, General and Administrative Expense of Revenue | 12.96% | 12.21% | 13.69% | 14.23% | |
| Intangible Assets out of Total Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Based Compensation of Revenue | 0.00% | 3.57% | 0.00% | 3.00% | |
| Graham Net Nets | (0.42) | (0.39) | (0.35) | (0.35) | |
| Graham Number | 0.99 | 0.82 | 0.74 | 0.88 | |
| Earnings Yield | (6.84%) | (5.64%) | (5.20%) | (5.08%) | |
| Free Cash Flow Yield | (26.07%) | (25.15%) | (32.19%) | (31.94%) | |
| Revenue per Share | 0.70 | 0.85 | 0.58 | 0.44 | |
| Operating CF per Share | 0.00 | (0.34) | 0.00 | (0.10) | |
| Capex per Share | 0.00 | (0.01) | 0.00 | (0.01) | |
| Free Cash Flow per Share | 0.00 | (0.36) | 0.00 | (0.11) | |
| Cash per Share | 0.03 | 0.06 | 0.05 | 0.05 | |
| Shareholders Equity per Share | (0.21) | (0.16) | (0.13) | (0.19) | |
| Interest Debt per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book value per Share | (0.21) | (0.16) | (0.13) | (0.19) | |
| Free Cash Flow | — | (75.14) | — | (22.89) | |
| Working Capital | (22.63) | (33.32) | (32.26) | (28.23) | |
| Capital Expenditures | — | (3.02) | — | (1.11) | |
| Net Current Asset Value | (283.85) | (272.52) | (260.57) | (262.63) | |
| EV/EBIT | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex to Sales | 0.00 | 0.02 | 0.00 | 0.01 | |
| Net Profit Margin | (9.13%) | (7.40%) | (7.18%) | (11.21%) | |
| Price to Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
| Average Receivables | 3.09 | 3.45 | 3.37 | 2.56 | |
| Average Payables | 10.16 | 10.54 | 10.00 | 10.86 | |
| Average Inventory | 43.68 | 52.03 | 38.36 | 27.16 | |
| Average Assets | 299.15 | 308.62 | 283.86 | 142.64 | |
| Average Common Equity | (44.54) | (40.31) | (35.41) | (40.20) |
Columns are period end dates